Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-29

FDA Approved: NALOXONE HYDROCHLORIDE — Original Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved Naloxone Hydrochloride as a generic product under an original application (ANDA 215964) by Par Health USA, LLC, for reversal of opioid overdose.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone Hydrochloride (Naloxone hydrochloride)

Snippet

ORIG AP for NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE)